Skip to main content

Antivenin Micrurus Fulvius use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Dec 15, 2023.

Antivenin Micrurus Fulvius Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the clinical use of antivenin Micrurus fulvius (coral snake antivenin) during breastfeeding. Because it is a mixture of large protein molecules, the amounts in milk are likely to be very low.[1] They are also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal.[2]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Stratigakis A, Paty D, Zou P, et al. A regression approach for assessing large molecular drug concentration in breast milk. Reprod Breed 2023;3:199-207. doi:10.1016/j.repbre.2023.10.003 [CrossRef]
2.
Anderson PO. Monoclonal antibodies during breastfeeding. Breastfeed Med 2021;16:591-3. [PubMed: 33956488]

Substance Identification

Substance Name

Antivenin Micrurus Fulvius

Drug Class

Breast Feeding

Lactation

Milk, Human

Antibodies

Antivenins

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.